Pharm. Ogechukwu Blessing Momah has emerged as one of the leading figures redefining regulatory practice and compliance strategy in Nigeria’s pharmaceutical sector.

Known for developing harmonisation protocols and for her role in resolving complex cross-border compliance disputes, her methods have become reference points in professional training sessions and policy discussions across Africa. In her advisory work with pharmaceutical companies, she introduced measures such as embassy-level authentication of documents, predictive approval timelines, and dynamic labelling systems, helping to streamline Nigeria’s entry strategies for foreign-manufactured drugs.

Colleagues say Momah’s work has shifted regulatory affairs from a back-office function to a core element of business strategy. Her interventions have shown that compliance, when intelligently designed, can enable innovation rather than restrict it.

Beyond technical expertise, Momah is also credited with mentoring young professionals and building capacity for the next generation of regulatory scientists. Through lectures, workshops, and collaborations with universities, she has highlighted the importance of precision and excellence in compliance roles that often receive limited visibility.

In a 2023 keynote at the African Regulatory Strategy Summit, she argued that Africa’s pharmaceutical future depends on frameworks rooted in its own realities. “We must build from our context, with rigour and with pride,” she told delegates.

Her commitment to developing indigenous capacity and aligning local standards with global expectations has made her a prominent voice in positioning regulation as a driver of industry transformation.